Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
If you miss it, there can be dire consequences
From consultations to prescriptions and ongoing support, we handle the details so you can focus on your health
Storage: Lyophilized: 28 C (35.646.4 F) or freeze at 20 C (4 F)
Pain and Irritation at Injection Site The most common reaction to B12 injections is pain, redness, swelling, or irritation, where the needle goes into your skin or muscle
